Mark R Tanner

Impact of Presence and Amount of Clonal Plasma Cells in Autografts Affect Outcomes in High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant

E. Shpall, R. Orlowski, Y. Nieto, 2022, Blood.

Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4:14): The MD Anderson Cancer Center Experience

E. Shpall, R. Orlowski, Y. Nieto, 2022, Blood.

MM-403 Impact of Clonal Plasma Cells in Autografts on the Outcome of High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant.

E. Shpall, R. Orlowski, Y. Nieto, 2022, Clinical lymphoma, myeloma & leukemia.

Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant

E. Shpall, R. Orlowski, Y. Nieto, 2023, British journal of haematology.

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

E. Shpall, R. Orlowski, Y. Nieto, 2023, Blood cancer journal.

Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience

R. Orlowski, Y. Nieto, Q. Bashir, 2024, Blood cancer journal.